Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment

Table of Contents

Chapter One: Executive Summary

• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends Affecting Market
• Leading Competitors

Chapter Two: Introduction

• Overview of Obesity and Weight Management
  • Definition of Overweight and Obesity
  • Homeostatic Mechanisms Controlling Energy Balance
    • Linking Energy Stores in Body Fat with the Hypothalamus
    • Insulin as the Sensor of Energy Stores in Fat
    • Integration and Effect on Energy Balance
  • Regulation of Energy Expenditure and Food Intake
    • Energy Expenditure
    • Food Intake
  • Pathophysiology of Obesity
    • Obesity Disorder of the Homeostatic Control of Energy Balance
    • Genetic Factors
    • Food Intake
    • Physical Exercise
  • Causes of Overweight and Obesity
    • Genetics
    • Environmental
    • Socioeconomic
  • Health Risks
  • Economic Consequences
• Demographics
• Obesity Management

Chapter Three: Issues and Trends

• Over-the Counter Xenical
• Cortisol and Obesity
• Weight and Height Trends
• Educational Efforts of Physical Activity
  • Sedentary Behavior in Overweight and Obese Persons
  • Role of Physical Activity in Body Weight Regulation
  • Educating Patients About the Benefits of Activity
    • Cardiovascular and All-Cause Mortality
    • Cardiovascular Risk Factors
    • Fat and Muscle During Weight Loss
    • Physical and Psychologic Well-being
    • Long-term Weight Maintenance
• Fat Gene Mapping Tool
• Laser Melts Fat
• Ciliary Neurotrophic Factor Update
• Drinking and Obesity
• Exercise Gene
• Trends in Childhood Obesity
• Effect of Modernization on Obesity
• Insurance Coverage Issues
  • Medicare
  • Medicaid
  • Medicare Coverage of Bariatric Surgery
• Selected Weight Loss Programs

Chapter Four: Prescription Pharmaceutical Market

• Description of Products
  • Appetite Suppressants
  • Sympathomimetic Amine
  • Monoamine Reuptake Inhibitor
  • Lipase Inhibitors
• Market Size and Growth
  • World Market
  • World Market and U.S. Market Analysis
  • Competitive Analysis

Chapter Five: Over-the-Counter Drugs

• Overview
• Description of Products
  • Appetite Suppressants
  • Noradrenergic Agents
  • Caffeine-based Agents
  • Benzocaine-Based Agents
  • Fat Substitutes
  • Others
  • 5HTP-Trptophan
  • Hoodia
• Market Size and Growth
  • World Market
  • World Market and U.S. Market Analysis
  • Competitive Analysis

Chapter Six: Surgical Interventions

• Overview
• Description of Products
  • Restrictive Surgery
  • Combined Restrictive and Malabsorptive Surgery
• Market Size and Growth
  • World Market
  • World Market and U.S. Market Analysis
  • Procedure Volumes

Chapter Seven: Pharmaceutical Research and Development

• Overview
• Description of Products
  • 5HT2-C Agonists
  • APD 356
  • WAY 629 & WAY 909
  • 5HT-6 Antagonists (BVT.5182)
  • Adiponectin (ACRP30 Famoxin)
  • Amylin Analogs (Symlin AC137)
  • Angiogenesis Inhibitors (TNP-470)
  • B-3AR Agonists
  • Botanical P57
  • Calpain-3
  • Cannabinoid-1 Receptor antagonists
  • Acomplia
  • L-000899055
  • SLV319
  • SR 147778
  • CCK-A Agonists
  • Cholesterol Metabolites (MSI-1436)
  • Cholesterol Transport Inhibitors (FM-VP4)
  • Ciliary Neurotrophic Factor (CNTF) (Axokine)
  • Extendin-4 (AC3174)
  • Fatty Acid Synthase Inhibitor (C75)
  • Fibroblast Growth Factor-1 Inhibitor
  • FIT Gene and Ion Channel (CSX121, CSX 102 and CXS-829)
  • Ghrelin Antagonist
  • Histamine-3 Antagonists
  • A-331440
  • NNC 0038-0000-1202
  • Human Growth Hormone Fragments (AOD 9604)
  • Leptin Agonists (CBT 1452)
  • Lipase Inhibitors
  • ATL 962
  • GT389-255
  • Melanin Concentrating Hormone-1 Receptor Antagonists
  • A-798
  • GW803430
  • NGX-1
  • SNAP 7941 SNAP94847
  • Melanocortin-4 Receptor Agonists
  • BIM-22103
  • NNC 70-619
  • Microsomal Triglyceride Transfer Protein (MTP) Inhibitor (SLx-4090)
  • Neuropeptide y2 Receptor Antagonist
  • Neuropeptide Y Agonist (TM30338 and TM30339)
  • Neuropeptide Y5 Receptor Antagonist (S-2367)
  • Nicotine Receptor Ligand (TC-2216/TC-2286)
  • Obestatin
  • Oleoyl-estrone
  • Oleoylethanolamide
  • Osmotin
  • Oxyntomodulin
  • Peroxisome Proliferator Activated Receptor (GW501516)
  • Peroxisome Proliferator Activated Receptor-Pan Agonist (DRL 11605)
  • Gut Hormone Peptide (PYY)
  • PPY3-36
  • AC 162352
  • Retinoid X Receptor: Peroxisome Proliferator Activated
  • Receptor Agonists (LG100268)
  • RIP140 Inhibitor
  • Selective Androgen Receptor Modulator (SARM) (Ostarine)
  • Stearoyl-COA Desaturase-1
  • Thyroid Hormone-B Receptor Agonist (KB-2115)
  • Vaccines (CYT009)
  • Others
  • BDC-03
  • BL-2040
  • HMR 1426
  • Orexin

Chapter Eight: World Market Summary

• Overview
• Total market Size and Forecast
• Competitor Analysis

Chapter Nine: Corporate Profiles

• Abbott Laboratories
• Alizyme
• Arena Pharmaceuticals
• ChemGenex Pharmaceuticals
• GlaxoSmithKline plc
• Ligand Pharmaceuticals, Inc
• Manhattan Pharmaceuticals, Inc
• Merck & Company, Inc.
• Metabolic Pharmaceuticals Limited
• Novartis
• Proctor & Gamble
• Regeneron Pharmaceuticals Inc
• Roche Group
• Sanofi-Aventis

Appendix: Company Directory